Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Sirnaomics Ltd. ( (HK:2257) ).
Sirnaomics Ltd. has announced the composition of its board of directors and their respective roles, highlighting a leadership structure that includes both executive and non-executive directors. The announcement outlines the membership of three key board committees, underscoring the governance framework within which the company operates. This organizational update is indicative of Sirnaomics’ commitment to structured corporate governance, potentially enhancing its operational efficiency and signaling stability to stakeholders.
More about Sirnaomics Ltd.
Sirnaomics Ltd. is a company incorporated in the Cayman Islands, focusing on advancing RNA interference (RNAi) therapeutics. The company is engaged in biotechnology, specifically in developing treatments using RNAi technology.
YTD Price Performance: -16.18%
Average Trading Volume: 179,381
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$292.4M
See more data about 2257 stock on TipRanks’ Stock Analysis page.